CD8A and type 1 diabetes mellitus: It has also been reported that the administration of one capsule per day containing 108 CFUs of LjN6.2 for 8 weeks in adult human subjects can regulate the infiltration of monocytes, natural killer cells, circulating Teff TH1 cells and cytotoxic CD8+ T cells in the islets; these changes may aid in the prevention of T1D occurrence [86].